|
LM_ID
|
Common Name
|
Systematic Name
|
Main class
|
Sub class
|
Mass
|
Formula
|
|
LMSP0502BE04
|
|
GalNAcalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
1675.98
|
C80H145N3O33
|
|
LMSP0502BL04
|
|
GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
1675.98
|
C80H145N3O33
|
|
LMSP0502BG04
|
|
Galbeta1-4GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
1675.98
|
C80H145N3O33
|
|
LMSP0502AF04
|
|
Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
1675.98
|
C80H145N3O33
|
|
LMSP0503AD04
|
|
Galbeta1-4GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Neutral glycosphingolipids [SP05]
|
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
|
1675.98
|
C80H145N3O33
|
|
LMSP0503AM04
|
|
GalNAcbeta1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Neutral glycosphingolipids [SP05]
|
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
|
1675.98
|
C80H145N3O33
|
|
LMSP0503AF04
|
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Neutral glycosphingolipids [SP05]
|
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
|
1675.98
|
C80H145N3O33
|
|
LMSP0504BR04
|
VI3(Galb 1-4GlcNAcb )-Lc4Cer(d18:1/22:0)
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
1675.98
|
C80H145N3O33
|
|
LMSP0504AL04
|
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
1675.98
|
C80H145N3O33
|
|
LMSP0505EL04
|
IV 3-nLcOse4(d18:1/22:0)
|
GalNAcbeta1-3Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
|
1675.98
|
C80H145N3O33
|
|
LMSP0505CB04
|
IV3Gala -nLc4Cer(d18:1/22:0)
|
Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
|
1675.98
|
C80H145N3O33
|
|
LMSP0505AL04
|
nLc6Cer(d18:1/22:0)
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
|
1675.98
|
C80H145N3O33
|
|
LMSP0505EJ04
|
|
Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
|
1675.98
|
C80H145N3O33
|
|
LMSP0505CF04
|
|
Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
|
1675.98
|
C80H145N3O33
|
|
LMSP0505BG04
|
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
|
1675.98
|
C80H145N3O33
|
|
LMSP0506AM04
|
|
Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
1675.98
|
C80H145N3O33
|
|
LMSP0506AK04
|
|
GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
1675.98
|
C80H145N3O33
|